Hematology Diagnostics Market Growth, Size, Trends Analysis- By Product, By Test Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Global Hematology Diagnostics Market Introduction and Overview

According to SPER Market Research, 'Global Hematology Diagnostics Market Size- By Product, By Test Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Global Hematology Diagnostics Market is estimated to reach USD 17.68 billion by 2033 with a CAGR of 4.64%.

Leukemia, coagulation issues, immune system disorders, anemia, and other blood illnesses are all detected and monitored by hematological diagnostics, a specialization of medical diagnostics that analyzes and tests blood and its constituent parts. Hemoglobin, platelets, white blood cells, red blood cells, and other parameters are among the many laboratory techniques and tests used to assess the composition and function of blood in order to inform treatment choices, monitor the course of the disease, and guarantee the patient's general health.

The COVID-19 pandemic had a major impact on the global market for hematological diagnostics in a number of ways. The need for thorough testing increased as hematological tests became crucial for tracking the health of COVID-19 patients and assessing how well they were responding to treatment. But supply chain interruptions brought on by the crisis also resulted in shortages of equipment, testing kits, and reagents that were required, which impacted market availability.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product, By Test Type, By End User

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation.

Hematology Diagnostics Market Segmentation:

By Product: Based on the Product, Global Hematology Diagnostics Market is segmented as; Instrument, Consumables.

By Test Type: Based on the Test Type, Global Hematology Diagnostics Market is segmented as; Blood Count, Platelet Function, Hemoglobin, Hematocrit.

By End User: Based on the End User, Global Hematology Diagnostics Market is segmented as; Hospitals, Diagnostic labs, Others.

By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.

Product Code: HLCA2489

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Hematology Diagnostics Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Hematology Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hematology Diagnostics Market

7. Global Hematology Diagnostics Market, By Product (USD Million) 2020-2033

7.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2020-2026
7.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2027-2033
7.3. Instrument
- 7.3.1. Analyzers
- 7.3.2. Flow cytometers
- 7.3.3. Others
7.4. Consumables
- 7.4.1. Analyzers
- 7.4.2. Flow cytometers
- 7.4.3. Others

8. Global Hematology Diagnostics Market, By Test Type (USD Million) 2020-2033

8.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2020-2026
8.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2027-2033
8.3. Blood count
8.4. Platelet function
8.5. Hemoglobin
8.6. Hematocrit

9. Global Hematology Diagnostics Market, By End User (USD Million) 2020-2033

9.1. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals
9.4. Diagnostic labs
9.5. Others

10. Global Hematology Diagnostics Market Forecast, 2020-2033 (USD Million)

10.1. Global Hematology Diagnostics Market Size and Market Share

11. Global Hematology Diagnostics Market, By Region, 2020-2033 (USD Million)

11.1. Global Hematology Diagnostics Market Size and Market Share By Region (2020-2026)
11.2. Global Hematology Diagnostics Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
- 11.3.1. Australia
- 11.3.2. China
- 11.3.3. India
- 11.3.4. Japan
- 11.3.5. South Korea
- 11.3.6. Rest of Asia-Pacific
11.4. Europe
- 11.4.1. France
- 11.4.2. Germany
- 11.4.3. Italy
- 11.4.4. Spain
- 11.4.5. United Kingdom
- 11.4.6. Rest of Europe
11.5. Middle East and Africa
- 11.5.1. Kingdom of Saudi Arabia
- 11.5.2. United Arab Emirates
- 11.5.3. Qatar
- 11.5.4. South Africa
- 11.5.5. Egypt
- 11.5.6. Morocco
- 11.5.7. Nigeria
- 11.5.8. Rest of Middle-East and Africa
11.6. North America
- 11.6.1. Canada
- 11.6.2. Mexico
- 11.6.3. United States
11.7. Latin America
- 11.7.1. Argentina
- 11.7.2. Brazil
- 11.7.3. Rest of Latin America

12. Company Profile

12.1. Abbott Laboratories
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Cardinal Health Inc.
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Danaher Corporation
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. EKF Diagnostics Holdings plc
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Erba Mannheim
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. F. Hoffmann-La Roche Ltd.
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Nihon Kohden Corporation
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Siemens AG
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Sysmex Corporation
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others